A Dutch trial for Covid-19 drug research will be the country's first to enable patients to digitally consent to their participation. It is hoped that this will reduce delays in trial enrolment.
US researchers have developed a way to use MRI scanning to map body cell metabolism, opening up new possibilities for detecting cancers and revealing if a tumor is responding to treatment.
A research team from DGIST develops an electronic medicine technology that restores abnormal protein behavior, the cause of Charcot-Marie-Tooth Disease (CMT).
Among all but oldest age groups, the US has higher death rates than five high-income European nations, according to new UCLA research. However, this gap is only partly due to Covid-19.
A UK research team has developed a new technique that combines machine learning with short-wave infrared (SWIR) fluorescence imaging to detect precise boundaries of tumors.
US scientists report using a single-atom-thick nanomaterial to simultaneously detect Covid-19 and flu viruses — at much lower levels and much more quickly than conventional tests for either.
Cambridge researchers have developed a new type of neural implant that could restore limb function to amputees and others who have lost the use of their arms or legs.
Chemotherapy resistance is a main cause of treatment failure and death in cancer patients. Researchers from Brussels found how cancer cells protect themselves from the aggressive treatment.
UK researchers have shown that misophonia, a condition where those affected show a strong negative reaction to everyday sounds, may affect almost one fifth of the general population.
New research has debunked the idea of an “obesity paradox”, whereby overweight or obese patients with heart failure are less likely to end up in hospital or die than people of normal weight.
A new real-time imaging technique that uses a type of infrared light has, for the first time, been used during surgery to differentiate between cancerous tumours and healthy tissue.
A recent survey of more than 8,000 patients found that users overwhelmingly supported receiving their test results immediately, even if their provider had not yet reviewed them.
A team of scientists has successfully generated genetically defined mouse models for two subtypes of multiple myeloma. This will contribute to a better understanding of how the disease develops in humans.
Omar Darwish, PhD student at King's College London, is researching new approaches to 3D MRE sequences for measuring liver fibrosis and inflammation simultaneously in obese patients.
Imaging researchers have taken a major step towards their ultimate goal of identifying cancers that are starved of oxygen so that altered treatment can be used to target them more effectively.
A new paper describes how generative AI text-to-image models such as DALL-E 2 could represent a promising future tool for image generation, augmentation, and manipulation in health care.
For pancreatic cancer, the effect of immunotherapy is limited and differs between men and women. Researchers at Karolinska Institutet have now found a possible explanation for this sex difference.
Researchers at the University of Barcelona have developed a new tool to assess the presence and severity of sarcopenia, using an ultrasound-based muscle quality scoring system.
Scientists have discovered why breast cancer cells that have spread to the lungs may ‘wake up’ following years of sleep - forming incurable secondary tumours.
A new ultrasound method that can measure the level of tension in human tissue for the first time - a key indicator of disease - has been developed by researchers from the University of Sheffield.
A new study by psychologists at the University of Vienna shows that there is no scientific evidence supporting the alleged positive effect of Mozart's Sonata KV448 on epilepsy.
New research suggests most people don’t understand the difference between a preprint and a published academic journal article. Here is the distinction between the two – and why it is important.
Researchers from the US, Singapore and Geneva have developed a novel combination therapy using an anticancer agent for treating vancomycin-resistant Enterococcus faecalis (VRE).
A pioneering new method to assess the quality of organs for donation has the potential to revolutionise the transplant system, saving lives and tens of millions of pounds.
Cancer cells have an innate randomness in their ability to respond to chemotherapy, which is another tool in their arsenal of resisting treatment, new research shows.
